Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Prevention and Treatment of Secondary Hyperparathyroidism associated with Chronic Kidney Disease (Stage 3 and 4) Condition: parathyroid hormone less than 500 pg/mL |
Dose: Oral – 1 mcg Frequency: once daily Note: Titrate dose based on response. Do not administer 3 times per week dosing more frequently than every other day. |
|
Indication: Prevention and Treatment of Secondary Hyperparathyroidism associated with Chronic Kidney Disease (Stage 3 and 4) Condition: parathyroid hormone less than 500 pg/mL |
Dose: Oral – 2 mcg Frequency: 3 times per week Note: Titrate dose based on response. Do not administer 3 times per week dosing more frequently than every other day. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Secondary hyperparathyroidism associated with chronic kidney disease (CKD) Age: 10 to 16 years Condition: Stages 3 and 4 |
Dose: Oral – 1 mcg Frequency: Three times weekly |
|
Indication: Secondary hyperparathyroidism associated with chronic kidney disease (CKD) Age: 10 to 16 years Condition: Stage 5 |
Dose: Oral – Baseline intact parathyroid hormone (pg/mL) divided by 120 Frequency: Three times weekly |
Administration
- May be taken with or without food
- Take at same time each day
Side Effect
- Nausea (13%)
- Vomiting
- Edema
- Palpitation
- Chills
- Pneumonia
- Lightheadedness
- GI bleeding
- Flu
- Sepsis
- Hypokalemia
- Hypercalcemia
- Increase in blood creatinine
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Digitalis
|
Potential interaction
|
|
Ketoconazole, Atazanavir, Clarithromycin, Indinavir, Itraconazole, Nefazodone, Nelfinavir, Ritonavir, Saquinavir, Telithromycin, Voriconazole
|
Potential interaction
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Hypercalcemia
|
Can worsen high calcium levels
|
|
Hypervitaminosis D
|
Risk of vitamin D toxicity
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.